MYELOPROLIFERATIVE DISORDER
Clinical trials for MYELOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled drug aims to stop lung infections in vulnerable blood cancer patients
Disease control Recruiting nowThis study tests an experimental inhaled drug called PUL-042 in 100 people with blood cancers or who have had a stem cell transplant and have a viral lung infection. Participants receive either the drug or a placebo three times over six days. The goal is to see if PUL-042 can red…
Matched conditions: MYELOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Pulmotect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cord blood transplant recipe aims to beat tough blood cancers
Disease control Recruiting nowThis study tests a standardized, optimized approach to cord blood transplantation for adults with high-risk blood cancers like leukemia and lymphoma. The method includes specific chemotherapy, radiation, and stem cell dosing, followed by careful monitoring. Researchers hope to im…
Matched conditions: MYELOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 15:21 UTC
-
Massive new study aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis long-term observational study is enrolling 5,000 adults with myeloproliferative neoplasms (MPNs)—rare blood cancers like polycythemia vera and myelofibrosis. Researchers will collect health records, patient surveys, and insurance data over at least five years to track sympto…
Matched conditions: MYELOPROLIFERATIVE DISORDER
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC